KEY POINTS:
The drug buying agency Pharmac will fund a once-a-day treatment for attention deficit hyperactivity disorder from the beginning of next month.
Concerta will be the third form of methylphenidate it subsidises.
Pharmac says the immediate-release and sustained-release versions it pays for now are effective but some people need to take doses several times a day and problems with compliance could lead to reduced effectiveness.
